136 related articles for article (PubMed ID: 35180720)
21. Marked Increase in Spinal Deformity Surgery Throughout the United States.
Beschloss A; Dicindio C; Lombardi J; Varthi A; Ozturk A; Lehman R; Lenke L; Saifi C
Spine (Phila Pa 1976); 2021 Oct; 46(20):1402-1408. PubMed ID: 33769412
[TBL] [Abstract][Full Text] [Related]
22. Complications, revision fusions, readmissions, and utilization over a 1-year period after bone morphogenetic protein use during primary cervical spine fusions.
Goode AP; Richardson WJ; Schectman RM; Carey TS
Spine J; 2014 Sep; 14(9):2051-9. PubMed ID: 24321129
[TBL] [Abstract][Full Text] [Related]
23. Current Trends in Recombinant Human Bone Morphogenetic Protein 2 (rhBMP2) Usage for Spinal Fusion Surgery.
Patel HA; Wellington IJ; Lubonja K; Stelzer JW; Antonacci CL; Coskun E; Cote MP; Singh H; Mallozzi SS; Moss IL
Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241110
[TBL] [Abstract][Full Text] [Related]
24. Use of bone morphogenetic proteins in spinal fusion surgery for older adults with lumbar stenosis: trends, complications, repeat surgery, and charges.
Deyo RA; Ching A; Matsen L; Martin BI; Kreuter W; Jarvik JG; Angier H; Mirza SK
Spine (Phila Pa 1976); 2012 Feb; 37(3):222-30. PubMed ID: 21494195
[TBL] [Abstract][Full Text] [Related]
25. Blood serum antibody analysis and long-term follow-up of patients treated with recombinant human bone morphogenetic protein-2 in the lumbar spine.
Burkus JK; Gornet MF; Glassman SD; Slosar PJ; Rosner MK; Deckey JE; Nowak J; Hatcher BM
Spine (Phila Pa 1976); 2011 Dec; 36(25):2158-67. PubMed ID: 21325990
[TBL] [Abstract][Full Text] [Related]
26. Use of bone morphogenetic protein among patients undergoing fusion for degenerative diagnoses in the United States, 2002 to 2012.
Martin BI; Lurie JD; Tosteson AN; Deyo RA; Farrokhi FR; Mirza SK
Spine J; 2015 Apr; 15(4):692-9. PubMed ID: 25523380
[TBL] [Abstract][Full Text] [Related]
27. Bone morphogenetic protein use in spine surgery-complications and outcomes: a systematic review.
Faundez A; Tournier C; Garcia M; Aunoble S; Le Huec JC
Int Orthop; 2016 Jun; 40(6):1309-19. PubMed ID: 26961193
[TBL] [Abstract][Full Text] [Related]
28. Reoperation Rates After Long Posterior Spinal Fusion: Use of Recombinant Bone Morphogenetic Protein in Idiopathic and Non-idiopathic Scoliosis.
Paul JC; Lonner BS; Vira S; Kaye ID; Errico TJ
Spine Deform; 2016 Jul; 4(4):304-309. PubMed ID: 27927521
[TBL] [Abstract][Full Text] [Related]
29. Complications related to osteobiologics use in spine surgery: a systematic review.
Mroz TE; Wang JC; Hashimoto R; Norvell DC
Spine (Phila Pa 1976); 2010 Apr; 35(9 Suppl):S86-104. PubMed ID: 20407355
[TBL] [Abstract][Full Text] [Related]
30. Neurologic impairment from ectopic bone in the lumbar canal: a potential complication of off-label PLIF/TLIF use of bone morphogenetic protein-2 (BMP-2).
Wong DA; Kumar A; Jatana S; Ghiselli G; Wong K
Spine J; 2008; 8(6):1011-8. PubMed ID: 18037352
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of Escherichia coli-derived recombinant human bone morphogenetic protein-2 in posterolateral lumbar fusion: an open, active-controlled, randomized, multicenter trial.
Cho JH; Lee JH; Yeom JS; Chang BS; Yang JJ; Koo KH; Hwang CJ; Lee KB; Kim HJ; Lee CK; Kim H; Suk KS; Nam WD; Han J
Spine J; 2017 Dec; 17(12):1866-1874. PubMed ID: 28652196
[TBL] [Abstract][Full Text] [Related]
32. BMP-2 induced early bone formation in spine fusion using rat ovariectomy osteoporosis model.
Park SB; Park SH; Kim NH; Chung CK
Spine J; 2013 Oct; 13(10):1273-80. PubMed ID: 23953506
[TBL] [Abstract][Full Text] [Related]
33. The efficacy of routine use of recombinant human bone morphogenetic protein-2 in occipitocervical and atlantoaxial fusions of the pediatric spine: a minimum of 12 months' follow-up with computed tomography.
Sayama C; Hadley C; Monaco GN; Sen A; Brayton A; Briceño V; Tran BH; Ryan SL; Luerssen TG; Fulkerson D; Jea A
J Neurosurg Pediatr; 2015 Jul; 16(1):14-20. PubMed ID: 25860982
[TBL] [Abstract][Full Text] [Related]
34. Use of Recombinant Bone Morphogenetic Protein Is Associated With Reduced Risk of Reoperation After Spine Fusion for Adult Spinal Deformity.
Paul JC; Lonner BS; Vira S; Kaye ID; Errico TJ
Spine (Phila Pa 1976); 2016 Jan; 41(1):E15-21. PubMed ID: 26335682
[TBL] [Abstract][Full Text] [Related]
35. Perioperative and long-term clinical outcomes for bone morphogenetic protein versus iliac crest bone graft for lumbar fusion in degenerative disk disease: systematic review with meta-analysis.
Noshchenko A; Hoffecker L; Lindley EM; Burger EL; Cain CM; Patel VV
J Spinal Disord Tech; 2014 May; 27(3):117-35. PubMed ID: 24945290
[TBL] [Abstract][Full Text] [Related]
36. Contralateral psoas seroma after transpsoas lumbar interbody fusion with bone morphogenetic protein-2 implantation.
Taher F; Lebl DR; Hughes AP; Girardi FP
Spine J; 2013 Feb; 13(2):e1-5. PubMed ID: 23321149
[TBL] [Abstract][Full Text] [Related]
37. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft.
Dimar JR; Glassman SD; Burkus KJ; Carreon LY
Spine (Phila Pa 1976); 2006 Oct; 31(22):2534-9; discussion 2540. PubMed ID: 17047540
[TBL] [Abstract][Full Text] [Related]
38. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
Miyazaki M; Sugiyama O; Tow B; Zou J; Morishita Y; Wei F; Napoli A; Sintuu C; Lieberman JR; Wang JC
J Spinal Disord Tech; 2008 Jul; 21(5):372-9. PubMed ID: 18600149
[TBL] [Abstract][Full Text] [Related]
39. The Effects of High-Dose Parathyroid Hormone Treatment on Fusion Outcomes in a Rabbit Model of Posterolateral Lumbar Spinal Fusion Alone and in Combination with Bone Morphogenetic Protein 2 Treatment.
Holmes CA; Ishida W; Elder BD; Lo SL; Chen YA; Kim E; Locke J; Taylor M; Witham TF
World Neurosurg; 2018 Jul; 115():e366-e374. PubMed ID: 29678698
[TBL] [Abstract][Full Text] [Related]
40. The perioperative cost of Infuse bone graft in posterolateral lumbar spine fusion.
Glassman SD; Carreon LY; Campbell MJ; Johnson JR; Puno RM; Djurasovic M; Dimar JR
Spine J; 2008; 8(3):443-8. PubMed ID: 17526436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
